Evidence map›Paper›PMID 32081129›Full record

ArticleeLife2020

Primary and secondary anti-viral response captured by the dynamics and phenotype of individual T cell clones.

Anastasia A Minervina, Mikhail V Pogorelyy, Ekaterina A Komech, Vadim K Karnaukhov, Petra Bacher, Elisa Rosati, Andre Franke, Dmitriy M Chudakov, Ilgar Z Mamedov, Yuri B Lebedev and 2 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 63 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. T cell transcriptional landscapes are shaped by TCR sequence similarity.bioRxiv : the preprint server for biology · 2025
    Article
  10. Article
  11. Article
  12. Computational detection of antigen-specific B cell receptors following immunization.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 4 countries.

Anastasia A MinervinaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation.ORCID 0000-0001-9884-6351
Mikhail V PogorelyyShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation.ORCID 0000-0003-0773-1204
Ekaterina A KomechShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation.
Vadim K KarnaukhovCenter of Life Sciences, Skoltech, Moscow, Russian Federation.
Petra BacherInstitute of Immunology, Kiel University, Kiel, Germany.
Elisa RosatiInstitute of Clinical Molecular Biology, Kiel University, Kiel, Germany.ORCID 0000-0002-2635-6422
Andre FrankeInstitute of Clinical Molecular Biology, Kiel University, Kiel, Germany.
Dmitriy M ChudakovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation.ORCID 0000-0003-0430-790X
Ilgar Z MamedovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation.
Yuri B Lebedev *Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation.ORCID 0000-0003-4554-4733
Thierry Mora *Laboratoire de physique de l'École normale supérieure, ENS, PSL, Sorbonne Université, Université de Paris, and CNRS, Paris, France.ORCID 0000-0002-5456-9361
Aleksandra M Walczak *Laboratoire de physique de l'École normale supérieure, ENS, PSL, Sorbonne Université, Université de Paris, and CNRS, Paris, France.ORCID 0000-0002-2686-5702
Christian-Albrechts-Universität zu Kiel · DECentre National de la Recherche Scientifique · FRPirogov Russian National Research Medical University · RUSkolkovo Institute of Science and Technology · RUCentral European Institute of Technology · CZInstitute of Bioorganic Chemistry · RULomonosov Moscow State University · RU

Funding

Deutsche Forschungsgemeinschaft 4096610003Deutsche Forschungsgemeinschaft Exc2167European Research Council 24208Ministry of Science and Higher Education of the Russian Federation 075-15-2019-1660Ministry of Science and Higher Education of the Russian Federation 075-15-2019-1789Russian Foundation for Basic Research 18-29-09132Russian Foundation for Basic Research 19-54-12011Russian Science Foundation 15-15-00178
6 · The paper itself

Abstract

The diverse repertoire of T-cell receptors (TCR) plays a key role in the adaptive immune response to infections. Using TCR alpha and beta repertoire sequencing for T-cell subsets, as well as single-cell RNAseq and TCRseq, we track the concentrations and phenotypes of individual T-cell clones in response to primary and secondary yellow fever immunization - the model for acute infection in humans - showing their large diversity. We confirm the secondary response is an order of magnitude weaker, albeit ∼10 days faster than the primary one. Estimating the fraction of the T-cell response directed against the single immunodominant epitope, we identify the sequence features of TCRs that define the high precursor frequency of the two major TCR motifs specific for this particular epitope. We also show the consistency of clonal expansion dynamics between bulk alpha and beta repertoires, using a new methodology to reconstruct alpha-beta pairings from clonal trajectories.

Indexed as

AdultEpitopesHigh-Throughput Nucleotide SequencingHumansImmunologic MemoryLymphocyte SubsetsMalePhenotypeReceptors, Antigen, T-CellTime FactorsT-LymphocytesTranscriptomeYellow FeverYellow Fever VaccineYellow fever virusEpitopesReceptors, Antigen, T-CellYellow Fever Vaccinecomputational biologyhumanimmunologyinflammationsingle-cellsystems biologyTCRvaccinationyellow fever

Identifiers

PMID32081129
PMCPMC7060039
OpenAlexW3008885059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.